Skip to main content

Spire Wealth Management

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1858740 MCLEAN, VA

Position in HALO

as of Mar 31, 2026 · filed Apr 22, 2026
Position Value
$477,680
-$106,214 QoQ
Shares Held
7,391
-14.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
19 quarters on record

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Spire Wealth Management holds $3,225,256 across 33 Biotechnology names. HALO ranks #2 (14.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
7,391 $477,680

All Filings in HALO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $477,680 7,391
2025-12-31 $583,894 8,676
2025-09-30 $363,473 4,956
2025-06-30 $7,386 142
2025-03-31 $907,824 14,227
2024-12-31 $6,789 142
2024-09-30 $8,128 142
2024-06-30 $9,738 186
2024-03-31 $7,566 186
2023-12-31 $4,287 116
2023-09-30 $23,531 616
2023-06-30 $18,035 500
2023-03-31 $19,095 500
2022-12-31 $29,758 523
2022-09-30 $22,893 579
2022-06-30 $7,180,184 163,186
2021-12-31 $80,942 2,013
2021-09-30 $2,481 61
2021-03-31 $83,921 2,013